Wordt geladen...
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
Neuroendocrine tumors are a rare and heterogeneous group of tumors with a variety of primary origins and variable aggressiveness. Platinum-based chemotherapy has been the cornerstone of treatment for the poorly differentiated tumors. However, well-differentiated neuroendocrine tumors are quite chemo...
Bewaard in:
Gepubliceerd in: | Onco Targets Ther |
---|---|
Hoofdauteurs: | , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Dove Medical Press
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4755420/ https://ncbi.nlm.nih.gov/pubmed/26929640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S72155 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|